Iron Deficiency in Heart Failure: Mechanisms and Pathophysiology.
Iron Deficiency in Heart Failure: Mechanisms and Pathophysiology.
复制标题
DOI:
10.3390/jcm11010125
复制
发表时间:
2021-12-27
影响因子:
3.9
通讯作者:
Grote Beverborg N
中科院分区:
文献类型:
--
作者:
Alnuwaysir RIS;Hoes MF;van Veldhuisen DJ;van der Meer P;Grote Beverborg N
Iron is an essential micronutrient for a myriad of physiological processes in the body beyond erythropoiesis. Iron deficiency (ID) is a common comorbidity in patients with heart failure (HF), with a prevalence reaching up to 59% even in non-anaemic patients. ID impairs exercise capacity, reduces the quality of life, increases hospitalisation rate and mortality risk regardless of anaemia. Intravenously correcting ID has emerged as a promising treatment in HF as it has been shown to alleviate symptoms, improve quality of life and exercise capacity and reduce hospitalisations. However, the pathophysiology of ID in HF remains poorly characterised. Recognition of ID in HF triggered more research with the aim to explain how correcting ID improves HF status as well as the underlying causes of ID in the first place. In the past few years, significant progress has been made in understanding iron homeostasis by characterising the role of the iron-regulating hormone hepcidin, the effects of ID on skeletal and cardiac myocytes, kidneys and the immune system. In this review, we summarise the current knowledge and recent advances in the pathophysiology of ID in heart failure, the deleterious systemic and cellular consequences of ID.
登录
查看更多内容
影响因子:
4.2
作者:
BEARD, J;TOBIN, B;GREEN, W
通讯作者:
GREEN, W
影响因子:
18.2
作者:
Anker, Stefan D.;Kirwan, Bridget-Anne;Ponikowski, Piotr
通讯作者:
Ponikowski, Piotr
影响因子:
18.2
作者:
通讯作者:
--
影响因子:
3.1
作者:
Bhandari, Sunil
通讯作者:
Bhandari, Sunil
影响因子:
64.8
作者:
Baughman, Joshua M.;Perocchi, Fabiana;Girgis, Hany S.;Plovanich, Molly;Belcher-Timme, Casey A.;Sancak, Yasemin;Bao, X. Robert;Strittmatter, Laura;Goldberger, Olga;Bogorad, Roman L.;Koteliansky, Victor;Mootha, Vamsi K.
通讯作者:
Mootha, Vamsi K.